OpenVSafe by OpenVAERS
Search V-safe

PQD-32042-82520

3 vaccinations 3 coded responses 38 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
554 / MN
Registered
2021-01-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-05
    Registered in v-safe
  2. 2021-01-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-05
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-01-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-12
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-19
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-26
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-29
    Dose 2 — Pfizer-BioNTech
  14. 2021-01-29
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  16. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness, Diarrhea
    Free text: Axillary lymphadenopathy on same side as injection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · Muscle or body aches
    Free text: Axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  19. 2021-02-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-05
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-02-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-26
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-30
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-30
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-12-31
    Dose 3 — Pfizer-BioNTech
  29. 2021-12-31
    Health check-in — day 0, dose 3
    Feeling: Fair · None
    Adult check-in
  30. 2022-01-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  31. 2022-01-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  32. 2022-01-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  33. 2022-01-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  34. 2022-01-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2022-01-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2022-01-09
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  37. 2022-01-14
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-01-21
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-01-30
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-02-11
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-04-01
    Survey response — 3 months, dose 3
    MedDRA: Dyspnoea, Fatigue, Pain — Feeling: Good · Be unable to work or attend school
    Free text: Shortness of breath, body aches, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-12-31
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-05Pfizer-BioNTech
22021-01-29Pfizer-BioNTech
32021-12-31Pfizer-BioNTech No

Free text

Release 3 — days 1–6 daily, dose 2

2021-01-31

Systemic reaction (other): Axillary lymphadenopathy on same side as injection

2021-02-01

Systemic reaction (other): Axillary lymphadenopathy

Release 11 — 3 months, dose 3

2022-04-01

Symptoms: Shortness of breath, body aches, fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDyspnoea · · ✓
SDFatigue · · ✓
SDPain · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…